Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore.

Dong D, Sung C, Finkelstein EA.

Neurology. 2012 Sep 18;79(12):1259-67. doi: 10.1212/WNL.0b013e31826aac73. Epub 2012 Sep 5.

PMID:
22955130
2.

Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand.

Rattanavipapong W, Koopitakkajorn T, Praditsitthikorn N, Mahasirimongkol S, Teerawattananon Y.

Epilepsia. 2013 Sep;54(9):1628-38. doi: 10.1111/epi.12325. Epub 2013 Jul 29.

3.

Association between HLA and Stevens-Johnson syndrome induced by carbamazepine in Southern Han Chinese: genetic markers besides B*1502?

Shi YW, Min FL, Qin B, Zou X, Liu XR, Gao MM, Wang Q, Zhou JQ, Liao WP.

Basic Clin Pharmacol Toxicol. 2012 Jul;111(1):58-64. doi: 10.1111/j.1742-7843.2012.00868.x. Epub 2012 Mar 17.

4.

HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese.

Cheung YK, Cheng SH, Chan EJ, Lo SV, Ng MH, Kwan P.

Epilepsia. 2013 Jul;54(7):1307-14. doi: 10.1111/epi.12217. Epub 2013 May 20.

5.

Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.

Hung SI, Chung WH, Liu ZS, Chen CH, Hsih MS, Hui RC, Chu CY, Chen YT.

Pharmacogenomics. 2010 Mar;11(3):349-56. doi: 10.2217/pgs.09.162.

PMID:
20235791
6.
7.

Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population.

Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Chen P, Lin SY, Chen WH, Konyoung P, Khunarkornsiri U, Auvichayapat N, Pavakul K, Kulkantrakorn K, Choonhakarn C, Phonhiamhan S, Piyatrakul N, Aungaree T, Pongpakdee S, Yodnopaglaw P.

Epilepsia. 2010 May;51(5):926-30. doi: 10.1111/j.1528-1167.2010.02533.x. Epub 2010 Mar 19.

8.

Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand.

Tiamkao S, Jitpimolmard J, Sawanyawisuth K, Jitpimolmard S.

Int J Clin Pharm. 2013 Aug;35(4):608-12. doi: 10.1007/s11096-013-9777-9. Epub 2013 May 7.

PMID:
23649893
9.

HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.

Kulkantrakorn K, Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Prabmechai N, Vannaprasaht S, Chumworathayi P, Chen P, Sritipsukho P.

Pain Pract. 2012 Mar;12(3):202-8. doi: 10.1111/j.1533-2500.2011.00479.x. Epub 2011 Jun 16.

PMID:
21676164
10.
11.

Genetic predictors of Stevens-Johnson syndrome and toxic epidermal necrolysis induced by aromatic antiepileptic drugs among the Chinese Han population.

Wang W, Hu FY, Wu XT, An DM, Yan B, Zhou D.

Epilepsy Behav. 2014 Aug;37:16-9. doi: 10.1016/j.yebeh.2014.05.025. Epub 2014 Jun 18.

PMID:
24949577
12.

Real-world cost-effectiveness of pharmacogenetic screening for epilepsy treatment.

Chen Z, Liew D, Kwan P.

Neurology. 2016 Mar 22;86(12):1086-94. doi: 10.1212/WNL.0000000000002484. Epub 2016 Feb 17.

PMID:
26888992
13.

Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans.

Kim SH, Lee KW, Song WJ, Kim SH, Jee YK, Lee SM, Kang HR, Park HW, Cho SH, Park SH, Min KU, Chang YS; Adverse Drug Reaction Research Group in Korea.

Epilepsy Res. 2011 Nov;97(1-2):190-7. doi: 10.1016/j.eplepsyres.2011.08.010. Epub 2011 Sep 13.

PMID:
21917426
14.

Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.

Chen P, Lin JJ, Lu CS, Ong CT, Hsieh PF, Yang CC, Tai CT, Wu SL, Lu CH, Hsu YC, Yu HY, Ro LS, Lu CT, Chu CC, Tsai JJ, Su YH, Lan SH, Sung SF, Lin SY, Chuang HP, Huang LC, Chen YJ, Tsai PJ, Liao HT, Lin YH, Chen CH, Chung WH, Hung SI, Wu JY, Chang CF, Chen L, Chen YT, Shen CY; Taiwan SJS Consortium.

N Engl J Med. 2011 Mar 24;364(12):1126-33. doi: 10.1056/NEJMoa1009717.

15.

Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.

Hsiao YH, Hui RC, Wu T, Chang WC, Hsih MS, Yang CH, Ho HC, Chang YG, Chen MJ, Lin JY, Chen DP, Chang PY, Wu TL, Hung SI, Chung WH.

J Dermatol Sci. 2014 Feb;73(2):101-9. doi: 10.1016/j.jdermsci.2013.10.003. Epub 2013 Oct 22.

PMID:
24268988
16.

HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs.

Park HJ, Kim YJ, Kim DH, Kim J, Park KH, Park JW, Lee JH.

Yonsei Med J. 2016 Jan;57(1):118-26. doi: 10.3349/ymj.2016.57.1.118.

17.

Association of HLA-B*1502 and *1511 allele with antiepileptic drug-induced Stevens-Johnson syndrome in central China.

Sun D, Yu CH, Liu ZS, He XL, Hu JS, Wu GF, Mao B, Wu SH, Xiang HH.

J Huazhong Univ Sci Technolog Med Sci. 2014 Feb;34(1):146-50. doi: 10.1007/s11596-014-1247-7. Epub 2014 Feb 6.

PMID:
24496695
18.

Association of carbamazepine-induced severe cutaneous drug reactions and HLA-B*1502 allele status, and dose and treatment duration in paediatric neurology patients in Singapore.

Chong KW, Chan DW, Cheung YB, Ching LK, Hie SL, Thomas T, Ling S, Tan EC.

Arch Dis Child. 2014 Jun;99(6):581-4. doi: 10.1136/archdischild-2013-304767. Epub 2013 Nov 13.

PMID:
24225276
19.

Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population.

Chang CC, Too CL, Murad S, Hussein SH.

Int J Dermatol. 2011 Feb;50(2):221-4. doi: 10.1111/j.1365-4632.2010.04745.x.

PMID:
21244392
20.

Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese.

Man CB, Kwan P, Baum L, Yu E, Lau KM, Cheng AS, Ng MH.

Epilepsia. 2007 May;48(5):1015-8. Erratum in: Epilepsia. 2008 May;49(5):941.

Supplemental Content

Support Center